Fig. 4.
Schematic of the procedure to rationally design an ERα that no longer responds to FPP while retaining responsiveness to estradiol (E2). This schematic is general to the design of any NR to be activated or not by any ligand.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.